RCM
Revelation Capital Management Portfolio holdings
AUM
$4.26M
This Quarter Return
-41.25%
1 Year Return
-80.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$27.4M
AUM Growth
+$27.4M
(-74%)
Cap. Flow
-$34.5M
Cap. Flow
% of AUM
-125.99%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
3
Closed
3
Top Buys
No buys this quarter
Top Sells
| 1 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$18.9M |
| 2 |
ME
23andMe Holding Co. Class A Common Stock
ME
|
$7.66M |
| 3 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
$4.32M |
| 4 |
Neuropace
NPCE
|
$2.35M |
| 5 |
Natera
NTRA
|
$739K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMIC
1
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $14M | 51.22% |
2,219,951
-3,000,000
| -57% | -$18.9M |
|
|
ME
2
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $10.2M | 37.36% |
2,667,736
-2,000,000
| -43% | -$7.66M |
|
|
3
Neuropace
NPCE
$303M
| $3.13M | 11.43% |
380,705
-285,835
| -43% | -$2.35M |
|
4
CVRx
CVRX
$205M
| – | – |
-38,182
| Closed | -$467K |
|
|
5
Natera
NTRA
$23.1B
| – | – |
-7,923
| Closed | -$739K |
|
|
SLGC
6
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| – | – |
-370,839
| Closed | -$4.32M |
|